Accelr8, BD Move Closer to Rapid Bacterial Dx Development Agreement | GenomeWeb
NEW YORK (GenomeWeb News) – Accelr8 Technology said today that it has reached an agreement in principle with Becton Dickinson to fund an 18-month milestone project for Accelr8’s rapid bacterial diagnostic system.
 
Under terms of the preliminary pact, BD will receive an option to license the resulting technology to develop and sell a clinical diagnostic system for infectious diseases.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.